Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human Study of PRD001 in Healthy Participants, Assessment of Safety, Tolerability and Pharmacokinetics of Single/Multiple Doses

NCT07034183 is registered in ClinicalTrials.gov with PRD Therapeutics, Inc. as lead sponsor.

NCT NCT07034183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07034183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human Study of PRD001 in Healthy Participants, Assessment of Safety, Tolerability and Pharmacokinetics of Single/Multiple Doses
Lead sponsor
PRD Therapeutics, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
June 19, 2025
Completion date
June 30, 2026
Enrollment
86 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers